Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

South Korea · Delayed Price · Currency is KRW

3,835.00

-255.00 (-6.23%)

Jun 26, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical	191.39B	162.68B	129.49B	196.93B	182.49B
Pharmaceutical Growth	17.65%	25.64%	-34.25%	7.91%	7.56%
Research and Development Department	10.69B	-	-	-	-
Consolidation Adjustments	-1.37B	-2.60B	-3.56B	-6.02B	-
Total	200.71B	160.09B	125.93B	190.91B	182.49B
Total Growth	25.38%	27.13%	-34.04%	4.61%	7.56%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea	190.38B	160.05B	125.78B	190.71B	182.43B
South Korea Growth	18.95%	27.25%	-34.05%	4.54%	7.64%
Overseas	10.34B	37.76M	149.84M	202.44M	61.00M
Overseas Growth	27275.07%	-74.80%	-25.99%	231.89%	-66.70%
Total	200.71B	160.09B	125.93B	190.91B	182.49B
Total Growth	25.38%	27.13%	-34.04%	4.61%	7.56%